176 related articles for article (PubMed ID: 18164420)
21. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Gotthardt M; Battmann A; Höffken H; Schurrat T; Pollum H; Beuter D; Gratz S; Béhé M; Bauhofer A; Klose KJ; Behr TM
Nucl Med Commun; 2004 May; 25(5):439-43. PubMed ID: 15100501
[TBL] [Abstract][Full Text] [Related]
22. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.
de Groot JW; Links TP; Jager PL; Kahraman T; Plukker JT
Ann Surg Oncol; 2004 Aug; 11(8):786-94. PubMed ID: 15289241
[TBL] [Abstract][Full Text] [Related]
23. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S105-9. PubMed ID: 12739343
[No Abstract] [Full Text] [Related]
24. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study.
Musholt TJ; Musholt PB; Dehdashti F; Moley JF
Surgery; 1997 Dec; 122(6):1049-60; discussion 1060-1. PubMed ID: 9426419
[TBL] [Abstract][Full Text] [Related]
25. Would patient selection based on both calcitonin blood level and doubling time improve 18F-FDG PET sensitivity in restaging of medullary thyroid cancer?
Aide N; Bardet S
J Nucl Med; 2007 Sep; 48(9):1574; author reply 1574-5. PubMed ID: 17785732
[No Abstract] [Full Text] [Related]
26. ¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.
Marzola MC; Rubello D
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):132-5. PubMed ID: 22498183
[No Abstract] [Full Text] [Related]
27. Functional nuclear medicine imaging of medullary thyroid cancer.
Bozkurt MF; Uğur O; Banti E; Grassetto G; Rubello D
Nucl Med Commun; 2008 Nov; 29(11):934-42. PubMed ID: 18836370
[TBL] [Abstract][Full Text] [Related]
28. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
29. Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.
Nanni C; Rubello D; Fanti S; Farsad M; Ambrosini V; Rampin L; Banti E; Carpi A; Muzzio P; Franchi R
Biomed Pharmacother; 2006 Sep; 60(8):409-13. PubMed ID: 16891093
[TBL] [Abstract][Full Text] [Related]
30. Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Esik O; Szavcsur P; Szakáll S; Bajzik G; Repa I; Dabasi G; Füzy M; Szentirmay Z; Perner F; Kásler M; Lengyel Z; Trón L
Cancer; 2001 Jun; 91(11):2084-95. PubMed ID: 11391589
[TBL] [Abstract][Full Text] [Related]
31. Avid 18F-FDG uptake in rectal hemorrhoid in a patient with metastatic medullary carcinoma of thyroid.
Basu S; Nair N
Indian J Gastroenterol; 2006; 25(5):257. PubMed ID: 17090847
[No Abstract] [Full Text] [Related]
32. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
Diehl M; Risse JH; Brandt-Mainz K; Dietlein M; Bohuslavizki KH; Matheja P; Lange H; Bredow J; Körber C; Grünwald F
Eur J Nucl Med; 2001 Nov; 28(11):1671-6. PubMed ID: 11702109
[TBL] [Abstract][Full Text] [Related]
33. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
Hassan A; Siddiqui M; Jahangir S
Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
[TBL] [Abstract][Full Text] [Related]
34. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Robbins RJ; Wan Q; Grewal RK; Reibke R; Gonen M; Strauss HW; Tuttle RM; Drucker W; Larson SM
J Clin Endocrinol Metab; 2006 Feb; 91(2):498-505. PubMed ID: 16303836
[TBL] [Abstract][Full Text] [Related]
35. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
Low SC; Sinha AK; Sundram FX
Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360
[TBL] [Abstract][Full Text] [Related]
36. Targeting Amyloids with [
Li C; Zhang P; Nie R; Gong X; Xie J; Yu Z; Wang C; Zhang H; Yan R; Lu Z
Mol Pharm; 2022 Feb; 19(2):584-591. PubMed ID: 34982563
[TBL] [Abstract][Full Text] [Related]
37. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
38. Thyroid metastasis from colorectal cancer: role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Malani AK; Gupta C; Rangineni S; Gupta V
Clin Colorectal Cancer; 2005 Nov; 5(4):287-91. PubMed ID: 16356308
[TBL] [Abstract][Full Text] [Related]
39. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
40. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
